Stereoselective glucuronidation of formoterol by human liver microsomes

British Journal of Clinical Pharmacology

Volumn 49, Issue 2, 2000, Pages 152-157

  Zhang, Mei ^a   Fawcett, J Paul ^a   Kennedy, Julia M ^a   Shaw, John P ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Formoterol; Human liver microsomes; Stereoselective glucuronidation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG MECHANISM; DRUG METABOLISM; ENANTIOMER; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER MICROSOME METABOLISM; MALE; MICHAELIS MENTEN KINETICS; NORMAL HUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; STEREOCHEMISTRY;

AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOLAMINES; GLUCURONATES; HUMANS; KINETICS; MALE; MICROSOMES, LIVER; MIDDLE AGED; STEREOISOMERISM; URIDINE DIPHOSPHATE GLUCURONIC ACID;

EID: 0033955814     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00133.x     Document Type: Article

References (24)

1. 1 Morgan DJ. Clinical pharmacokinetics of β-agonists. Clin Pharmacokinet 1990; 18: 270-294.
2. 2-agonists in asthma treatment. In Lung Biology in Health and Disease, Vol 106, eds. Pauwels R, O'Byrne PM, New York: Marcel Dekker Inc, 1997: 87-130.
3. 3 Boulton DW, Fawcett JP. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol 1996; 41: 35-40.
4. 4 Borgstrom L, Nyberg L, Jonsson S, Lindberg C, Paulson J. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol 1989; 27: 49-56.
5. 5 Walle T, Walle UK. Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol. Br J Clin Pharmacol 1990; 30: 127-133.
6. 6 Walle UK, Pesola GR, Walle T. Stereoselective sulphate conjugation of salbutamol in humans: Comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol 1993; 35: 413-418.
7. 7 Wilson AA, Wang J, Koch P, Walle T. Stereoselective sulphate conjugation of fenoterol by human phenolsulphotransferases. Xenobiotica 1997; 27: 1147-1154.
8. 8 Boulton DW, Fawcett JP. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans. Clin Pharmacol Ther 1997; 62: 138-144.
9. 9 Newman SP, Woodman G, Clarke SW, Sackner MA. Enhanced drug delivery from metered dose inhalers with InspirEase. Am Rev Respir Dis 1985; 131: A96.
10. 10 Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 52-55.
11. 11 Trofast J, Osterberg K, Kallstrom BL, Waldeck B. Steric aspects of agonism and antagonism at β-adrenoceptors: Synthesis of and pharmacological experiments with the enantiomers of formoterol and their diastereomers. Chirality 1991; 3: 443-450.
12. 12 Kamimura H, Sasaki H, Higuchi S, Shiobara Y. Quantitative determination of the β-adrenoceptor stimulant formoterol in urine by gas chromatography mass spectrometry. J Chromatogr 1982; 229: 337-345.
13. 13 Butter JJ, Berg BTJ, Portire EJG, Kaiser G, Boxtel CJ. Determination by HPLC with electrochemical detection of formoterol enantiomers in urine of healthy human subjects after single dose racemate inhalations. Pharm World Sci 1995; 17(Suppl): D6.
14. 14 Robson RA, Mathews AP, Miners JO, et al. Characterisation of theophylline metabolism in human liver microsomes. Br J Clin Pharmacol 1987; 24: 293-300.
15. 15 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
16. 16 Henderson PJF. Enzyme Assays. A Practical Approach. In The Practical Approach Series, eds. Eisenthal R, Danson MJ New York. Oxford University Press, 1992: 277-313.
17. 17 Arvidsson P, Larsson S, Lofdahl CG. Objective and subjective bronchodilation over 12 hours after inhaled formoterol: individual responses. J Asthma 1993; 30: 459-465.
18. 18 Temellini A, Giuliani L, Pacifici GM. Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver. Br J Clin Pharmacol 1991; 31: 661-664.
19. 19 Lacarelle B, Rajaonarison JF, Catalin J, Durand A, Cano JP. UDP-glucuronosyltransferase activity toward digitoxigenin monodigitoxoside in human liver microsomes. Drug Metab Dispos 1992; 21: 338-341.
20. 20 Burchell B, Coughtric MWH. UDP-Glucuronosyltransferases. In International Encyclopedia of Pharmacology and Therapeutic, Section 137. ed. Kalow W, New York: Pergamon Press. 1992: 195-225.
21. 21 Kroemer HK, Klote U. Glucuronidation of drugs, Clin Pharmacokinet 1992; 23: 292-310.
22. 22 Dahl-Puustinen ML, Dumont E, Bertilsson L. Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney and intestine: Organ-specific differences in enantioselectivity. Drug Metab Dispos 1989; 17: 433-436.
23. 23 Dumont E, Bahr CV, Perry TJ, Bertilsson L. Glucuronidation of the enantiomers of E-10-hydroxynortriptyline in man and rat liver microsomes. Pharmacol Toxicol 1987; 61: 335-341.
24. 24 Batt AM, Magdalou J, Vincent-Viry M, et al. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltranferases. Clin Chim Acta 1994; 226: 171-190.